Lawson Kroeker Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Buy
27,058
+13,597
+101% +$6.53M 3.76% 8
2026
Q1
$6.62M Sell
13,461
-586
-4% -$318K 1.93% 20
2025
Q4
$8.14M Sell
14,047
-1,735
-11% -$981K 2.42% 17
2025
Q3
$7.65M Buy
15,782
+156
+1% +$72.6K 1.4% 23
2025
Q2
$6.34M Buy
15,626
+123
+0.8% +$51.4K 1.18% 30
2025
Q1
$7.71M Sell
15,503
-252
-2% -$136K 1.42% 24
2024
Q4
$8.2M Sell
15,755
-421
-3% -$231K 1.54% 22
2024
Q3
$10M Sell
16,176
-138
-0.8% -$81.7K 1.82% 19
2024
Q2
$9.02M Sell
16,314
-305
-2% -$175K 1.74% 21
2024
Q1
$9.66M Sell
16,619
-236
-1% -$132K 1.83% 19
2023
Q4
$8.95M Buy
16,855
+279
+2% +$135K 1.84% 19
2023
Q3
$8.39M Buy
16,576
+25
+0.2% +$13.3K 1.85% 19
2023
Q2
$8.64M Sell
16,551
-230
-1% -$124K 2.07% 18
2023
Q1
$9.67M Sell
16,781
-419
-2% -$236K 2.17% 17
2022
Q4
$9.47M Sell
17,200
-655
-4% -$347K 3.2% 12
2022
Q3
$9.06M Sell
17,855
-85
-0.5% -$47.6K 3.19% 12
2022
Q2
$9.75M Sell
17,940
-490
-3% -$270K 3.29% 10
2022
Q1
$10.9M Buy
18,430
+93
+0.5% +$53.4K 3.43% 11
2021
Q4
$12.2M Sell
18,337
-443
-2% -$277K 3.8% 8
2021
Q3
$10.7M Buy
18,780
+60
+0.3% +$32.9K 3.56% 8
2021
Q2
$9.44M Buy
18,720
+30
+0.2% +$14.2K 2.99% 14
2021
Q1
$8.53M Buy
18,690
+1,350
+8% +$644K 2.92% 14
2020
Q4
$8.08M Sell
17,340
-970
-5% -$455K 3.03% 14
2020
Q3
$8.08M Sell
18,310
-60
-0.3% -$24.8K 3.61% 9
2020
Q2
$6.66M Sell
18,370
-150
-0.8% -$50.3K 3.14% 11
2020
Q1
$5.25M Sell
18,520
-1,400
-7% -$441K 2.92% 14
2019
Q4
$6.47M Sell
19,920
-375
-2% -$114K 2.39% 14
2019
Q3
$5.91M Hold
20,295
2.25% 16
2019
Q2
$5.96M Buy
20,295
+50
+0.2% +$13.8K 2% 19
2019
Q1
$5.54M Sell
20,245
-125
-0.6% -$31.1K 1.98% 19
2018
Q4
$4.56M Sell
20,370
-100
-0.5% -$23.5K 1.79% 21
2018
Q3
$5M Hold
20,470
1.62% 23
2018
Q2
$4.24M Hold
20,470
1.51% 27
2018
Q1
$4.23M Sell
20,470
-170
-0.8% -$35.7K 1.38% 28
2017
Q4
$3.92M Sell
20,640
-305
-1% -$58.4K 1.26% 29
2017
Q3
$3.96M Sell
20,945
-25
-0.1% -$4.53K 1.25% 30
2017
Q2
$3.66M Sell
20,970
-50
-0.2% -$8.4K 1.23% 31
2017
Q1
$3.23M Sell
21,020
-900
-4% -$138K 1.09% 31
2016
Q4
$3.09M Hold
21,920
1.06% 31
2016
Q3
$3.49M Sell
21,920
-825
-4% -$127K 1.13% 30
2016
Q2
$3.36M Sell
22,745
-220
-1% -$32.5K 1.12% 30
2016
Q1
$3.25M Sell
22,965
-50
-0.2% -$6.7K 1.12% 30
2015
Q4
$3.27M Sell
23,015
-750
-3% -$100K 1.13% 30
2015
Q3
$2.91M Sell
23,765
-175
-0.7% -$22.8K 0.97% 35
2015
Q2
$3.11M Sell
23,940
-300
-1% -$39.1K 0.92% 36
2015
Q1
$3.26M Hold
24,240
0.95% 34
2014
Q4
$3.04M Buy
24,240
+20
+0.1% +$2.43K 0.95% 37
2014
Q3
$2.95M Sell
24,220
-75
-0.3% -$9.12K 0.88% 35
2014
Q2
$2.87M Hold
24,295
0.83% 36
2014
Q1
$2.92M Sell
24,295
-2,000
-8% -$238K 0.91% 36
2013
Q4
$2.93M Buy
26,295
+275
+1% +$27.3K 0.93% 36
2013
Q3
$2.4M Hold
26,020
0.8% 38
2013
Q2
$2.2M Buy
+26,020
New +$2.17M 0.77% 37

Other funds holding TMO

Lawson Kroeker Investment Management's TMO Position: Q2 2026 in Review

Lawson Kroeker Investment Management increased its Thermo Fisher Scientific (TMO) stake by 101% in Q2 2026, buying an estimated $6.53M and bringing the position to 27,058 shares worth $13.6M. The position accounts for 3.76% of the portfolio, ranked #8.

Lawson Kroeker Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lawson Kroeker Investment Management held 27,058 shares of Thermo Fisher Scientific worth $13.6M as of Q2 2026.
  • Lawson Kroeker Investment Management bought 13,597 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.53M.
  • Thermo Fisher Scientific made up 3.76% of Lawson Kroeker Investment Management's portfolio in Q2 2026, its #8 holding.
  • Lawson Kroeker Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • 1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lawson Kroeker Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.